| Acquirer | Target | Price |
|---|---|---|
| Octopharma AG | License to Glycotope’s recombinant technology | $90.9 million |
| Nassua Reinsurance Group | UAM's Traditional Insurance business | $63 million |
| AmerisourceBergen Corp. | PharMEDium Healthcare Holdings | $2.58 billion |
| Partners Pharmacy | Tech Pharmacy Services, Inc. | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
